U.S. Video

Agios CEO: We have two medicines that will change lives

18 Mins Ago

David Schenkein, Agios CEO, speaks to CNBC's Meg Tirrell about his company's pyruvate kinase deficiency drug, stock performance and innovation.

Lavish Tips
Fat Rate Guaranteed
No Happy Hour Allowed